PrednisoneInflammationVincristineInflammation MediatorsCyclophosphamideGlucocorticoidsAnti-Inflammatory AgentsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsPrednisoloneMechlorethamineImmunosuppressive AgentsAzathioprineTreatment OutcomeDrug Therapy, CombinationMelphalanDisease Models, AnimalMice, Inbred C57BLMitoxantroneAntibodies, Monoclonal, Murine-DerivedDrug Administration ScheduleBleomycinCytokinesLungMethotrexateTime FactorsColor TherapyMice, KnockoutPneumoniaRemission InductionCyclosporineChlorambucilLymphoma, Non-HodgkinTumor Necrosis Factor-alphaAdrenal Cortex HormonesC-Reactive ProteinAsthmaNeurogenic InflammationBiological MarkersAdministration, OralFollow-Up StudiesInterleukin-6Hodgkin DiseaseNeutrophilsMycophenolic AcidBronchoalveolar Lavage FluidLymphoma, Large B-Cell, DiffuseChronic DiseaseArthritis, RheumatoidKidney TransplantationVinblastineMacrophagesThalidomideDose-Response Relationship, DrugAsparaginaseMultiple MyelomaColitisGraft RejectionLipopolysaccharidesSurvival AnalysisRecurrenceOvalbuminProspective StudiesEtoposideMethylprednisoloneCells, CulturedEosinophilsAcute DiseaseSurvival RateTacrolimusMice, Inbred BALB CDermatitisRespiratory HypersensitivityDexamethasoneDisease-Free SurvivalAnti-Inflammatory Agents, Non-SteroidalSignal TransductionCarrageenanLeukocyte CountNF-kappa BInterleukin-1betaBronchial HyperreactivityDouble-Blind MethodAntibodies, MonoclonalDisease ProgressionEosinophiliaPrognosisCombined Modality TherapySeverity of Illness IndexNephrotic SyndromeBiopsyChemokinesPolymyalgia RheumaticaClinical Trials as TopicRetrospective StudiesNeutrophil InfiltrationLeukocytesInfection6-Mercaptopurine